- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease ; volume:9 ; number:1 ; day:30 ; month:7 ; year:2019 ; pages:1-7 ; date:12.2019
EJNMMI Research ; 9, Heft 1 (30.7.2019), 1-7, 12.2019
- Urheber
-
Laban, Kamil G.
Kalmann, Rachel
Leguit, Roos J.
Keizer, Bart de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-019-0530-9
- URN
-
urn:nbn:de:101:1-2019122504374884545436
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Laban, Kamil G.
- Kalmann, Rachel
- Leguit, Roos J.
- Keizer, Bart de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled splitting
Labelled superposition
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy
24 Zirconium.
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled splitting
Labelled superposition
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy
24 Zirconium.
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled splitting
Labelled superposition
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy